Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

Posted on By Jeff Teitelbaum

Claire M. Zagorski, Rebecca A. Hosey, Christopher Moraff, Aaron Ferguson, Mary Figgatt, Shoshana Aronowitz, Natalie E. Stahl, Lucas G. Hill, Zoe McElligott & Nabarun Dasgupta

Harm Reduction Journal; 20:141; 2023

Access article

Chemistry, Forensic Pathology and Medicolegal Death Investigation, Seized Drugs/Controlled Substances, Toxicology